William A. Hagstrom

Biolytx Pharmaceuticals Corp. operates as a development stage company. The company was founded by William A. Hagstrom and H. Anne Pereira in 2005 and is headquartered in Oklahoma City, OK.

Octave Bioscience, Inc. operates as an early-stage diagnostics company which provides healthcare services. It focuses on neurodegenerative diseases and conditions. The company was founded by William A. Hagstrom in 2014 and is headquartered in Menlo Park, CA.

Genalyte, Inc. specializes in instrumentation and multiplex assays for biomarker and protein detection. The firm offers autoantibody testing assays for autoimmune research, custom assay services and maverick detection system. The company was founded in 2007 by Lawrence Cary Gunn III and is headquartered in San Diego, CA.

Selexys Pharmaceuticals Corp. operates as a biopharmaceutical company, which focuses on development of therapeutics for the treatment of inflammation, thrombosis and metastasis across a broad range of severe diseases. The firm solutions are used to treat vasoocclusion and thrombosis, such as vasoocclusive pain crisis in sickle cell disease and deep venous thrombosis; chronic inflammatory diseases and formation of atherosclerotic plaques. The company was founded by Richard D. Cummings, Richard Alvarez and Rodger P. McEver in 2002 and is headquartered in Oklahoma, OK.

Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA.

Cofactor Genomics, Inc. operates as a biotech company that offers services to the life-science, pharmaceutical, agriculture, and biofuels companies. The firm provides human genome projects. The company was founded by Jarret Glasscock, Dave Messina, and Jon Armstrong in 2008 and is headquartered in San Francisco, CA.

ZymeTx, Inc is a biotechnology company, which is engaged in the discovery, development and commercialization of products used to diagnose and treat viruses. The company's ViraZme technology focuses on the development of molecules that interacts with an enzyme of specific origin, such as viral, mammalian or bacterial origin. It was founded in 1994 and is headquartered in Oklahoma City, OK.